Genelux

• Home
• About
  1. Board of Directors
  2. Management
  3. Science Division
  4. Business Division
  5. Advisory Boards
• Technology
  1. Therapy
  2. Imaging
• Products
  1. GL-ONC1
  2. Future Products
• Clinical Trials
  1. About Clinical Trials
• Patents & Publications
  1. Scientific Publications
  2. Intellectual Property
• News & Events
  1. Press Releases
  2. In The News
  3. Events & Conferences
  4. Media Relations Contact
• Investor Relations
• Careers
• Contact

Intellectual Property

Genelux Corporation has an extensive intellectual property portfolio relating to GL-ONC1 and the next generation products and business lines. The portfolio includes issued patents and pending applications in various countries throughout the world. So that we can provide appropriate and specifically tailored responses, please send inquiries concerning Genelux’s intellectual property to Info@genelux.com.